Informazione:
Errore:
ID
34354
Descrizione
Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01287715
collegamento
https://clinicaltrials.gov/show/NCT01287715
Keywords
versioni (1)
- 16/01/19 16/01/19 -
Titolare del copyright
see on clinicaltrials.gov
Caricato su
16 gennaio 2019
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Eligibility Juvenile Idiopathic Arthritis NCT01287715
Eligibility Juvenile Idiopathic Arthritis NCT01287715
- StudyEvent: Eligibility
Similar models
Eligibility Juvenile Idiopathic Arthritis NCT01287715
- StudyEvent: Eligibility
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
ID.1
Item
diagnosis of juvenile idiopathic arthritis (all subtypes) by the international league of associations of rheumatology (ilar) criteria
boolean
ID.2
Item
on etanercept therapy
boolean
ID.3
Item
no mtx or low dose mtx (maximum 10 mg/m2)
boolean
ID.4
Item
3 or more months in remission according to the criteria of wallace (i.e. 9 or more months of inactive disease)
boolean
ID.5
Item
age ≥4 and <18 years at start of study
boolean
ID.6
Item
written informed consent from parents and patients 12 years and over
boolean
ID.7
Item
systemic corticosteroids (up to 9 months prior to inclusion)
boolean
ID.8
Item
intra-articular corticosteroids (up to 6 months prior to inclusion)
boolean
ID.9
Item
synthetic dmards besides low dose mtx (up to 9 months prior to inclusion)
boolean
ID.10
Item
biologic dmards besides etanercept (up to 9 months prior to inclusion)
boolean